Skip to content

Spontaneous coronary artery dissection (SCAD) study

Epidemiology, management, outcomes and pathophysiology of SCAD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN42661582
Enrollment
1000
Registered
2019-06-10
Start date
2013-08-19
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spontaneous coronary artery dissection Circulatory System

Interventions

The study has two elements. The first is an observational registry. Consenting patients allow access to their medical information and clinical imaging at the time and following their Spontaneous Coro

Sponsors

University of Leicester
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with angiographically proven SCAD (confirmed by the study team). 2. Healthy volunteers

Exclusion criteria

Exclusion criteria: Iatrogenic, atherosclerotic or traumatic dissections

Design outcomes

Primary

MeasureTime frame
1. Presenting clinical data from index admission with Spontaneous Coronary Artery Dissection, review of patient notes and imaging, at baseline 2. Demographic, medical, obstetric, contraceptive and family history, review of patient notes, online (bespoke) questionnaires, patient interview, at time of registration 3. Coronary angiographic findings, patient imaging data, at baseline 4. MACCE, SCAD recurrence, pregnancy at follow-up, questionnaires clarified by patient interview if required, annually

Secondary

MeasureTime frame
1. CMR assessment of myocardial function and infarct size, either from scans conducted on clinical grounds or research scans arranged as part of the phenotyping study 2. MRA/CTA assessment of remote arteriopathies either from scans conducted on clinical grounds or research scans arranged as part of the phenotyping study 3. USS assessment of arteries including FMD, IMT, luminal dimensions arranged as part of the phenotyping study 4. Cardiopulmonary exercise testing arranged as part of the phenotyping study 5. Ambulatory ECG monitoring conducted either on clinical grounds or arranged as part of the phenotyping study 6. Blood sampling for biomarkers and genetic studies 7. Skin biopsies for fibroblast culture for laboratory assays

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026